Related references
Note: Only part of the references are listed.The peroxisome proliferator-activated receptor alpha agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung
Julien Becker et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2012)
Evidence for the efficacy of statins in animal stroke models: a meta-analysis
Lidia Garcia-Bonilla et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α
Emanuela Esposito et al.
JOURNAL OF NEUROINFLAMMATION (2012)
PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure
Barbara Rinaldi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function
Elizabeth Gray et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Statin use prior to ischemic stroke onset is associated with decreased in-hospital mortality
Yahaya Hassan et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2011)
Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice
Guangming Wang et al.
NEUROSCIENCE RESEARCH (2011)
Statins and inflammation: an update
Petter Quist-Paulsen
CURRENT OPINION IN CARDIOLOGY (2010)
Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice
Qingmin Guo et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
The Science of Stroke: Mechanisms in Search of Treatments
Michael A. Moskowitz et al.
NEURON (2010)
Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice
Qingmin Guo et al.
BRAIN RESEARCH (2009)
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators
Diana Amantea et al.
FEBS JOURNAL (2009)
Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection
Thavarak Ouk et al.
VASCULAR PHARMACOLOGY (2009)
Cross-talk between statins and PPAR alpha in cardiovascular diseases: Clinical evidence and basic mechanisms
Rejane Paumelle et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Statins activate peroxisome proliferator-activated receptor γ through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages
Miyuki Yano et al.
CIRCULATION RESEARCH (2007)
PPAR:: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases
R. Bordet et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications
Rhian M. Touyz et al.
VASCULAR PHARMACOLOGY (2006)
Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: Relevance to multiple sclerosis
Igal Ifergan et al.
ANNALS OF NEUROLOGY (2006)
The role of the peroxisome proliferator-activated receptor-α (PPAR-α) in the regulation of acute inflammation
Salvatore Cuzzocrea et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-α via inhibition of the protein kinase C signaling pathway
R Paumelle et al.
CIRCULATION RESEARCH (2006)
Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat
L Zhang et al.
CIRCULATION (2005)
Statins and stroke
M Endres
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Targeting eNOS for stroke protection
M Endres et al.
TRENDS IN NEUROSCIENCES (2004)
Peroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cells
K Goya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS
S Moreno et al.
NEUROSCIENCE (2004)
Atorvastatin treatment induced peroxisome proliferator-activated receptor α expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats
N Roglans et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Fibrate and statin synergistically increase the transcriptional activities of PPARα/RXRα and decrease the transactivation of NFκB
I Inoue et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance
R Bordet et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Share Paper
